Patients with T2D who received GLP-1RAs or SGLT2 inhibitors were not associated with an increased risk for ARDs compared with DPP4 inhibitors.

BOSTON, March 3, 2026 /PRNewswire/ -- Skyhawk Therapeutics, Inc., a clinical-stage biotechnology company developing novel small molecule therapies designed to modulate critical RNA targets for a ...

Skyhawk Therapeutics, Inc., a clinical-stage biotechnology company developing novel small molecule therapies designed to modulate critical RNA targets for a series of challenging neurological diseases ...

A study published in BMC Infectious Diseases has found that older patients with sepsis have lower 28-day mortality when blood pressure is maintained within an optimal range. Current ...

Patients with type 2 diabetes who received sodium-glucose cotransporter-2 inhibitors demonstrated a nearly 50% lower risk for systemic autoimmune rheumatic disease vs. those who received dipeptidyl ...

Tirzepatide use is linked to lower risks of incident and progressive diabetic retinopathy compared with lifestyle intervention alone.

Results from Asia suggest chronic rhinosinusitis is associated with an increased risk for cancer, but whether these results ...

“统计大讲堂”由中国人民大学统计学院与应用统计科学研究中心联合主办，旨在搭建学界与业界的交流平台，促进统计理论与实践的深度融合，推动统计学科研创新，服务国家经济社会发展。作为统计学院人才培养体系的核心组成部分，“统计大讲堂”通过系列学术讲座、专题研讨等形式，为统计学子提供前沿知识传授与学术思维训练，营造开放包容的学术氛围，以培养具有国际视野、创新能力和实践精神的复合型统计人才。 返回搜狐，查看更多 ...

Among patients with asthma without diabetes, the risk for exacerbation was decreased with GLP-1 receptor agonist exposure, ...

year findings call for physicians to balance the benefits of the medication for weight loss with the rupture risks, particularly for tendons that do the heavy lifting.

Q4 2025 . Management View. Curran Simpson, President and CEO, stated, "2026 is set to be a pivotal year for REGENXBIO with great focu ...

Can the neurovascular effects of GLP-1s play a role in treating migraine?